• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clonal hematopoiesis in patients with Covid-19 is stable and not linked to an aggravated clinical course.

作者信息

Petzer Verena, Schwendinger Simon, Haschka David, Vogi Verena, Tymoszuk Piotr, Burkert Francesco, Sahanic Sabina, Sonnweber Thomas, Bellmann-Weiler Rosa, Loeffler-Ragg Judith, Tancevski Ivan, Zschocke Johannes, Weiss Guenter, Wolf Dominik, Jukic Emina

机构信息

Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Austria.

Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Am J Hematol. 2021 Sep 1;96(9):E331-E333. doi: 10.1002/ajh.26251. Epub 2021 Jun 2.

DOI:10.1002/ajh.26251
PMID:34028864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8212118/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ca/8212118/90f0d65f8296/AJH-96-E331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ca/8212118/90f0d65f8296/AJH-96-E331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2ca/8212118/90f0d65f8296/AJH-96-E331-g001.jpg

相似文献

1
Clonal hematopoiesis in patients with Covid-19 is stable and not linked to an aggravated clinical course.新冠病毒肺炎患者的克隆性造血是稳定的，且与病情加重无关。
Am J Hematol. 2021 Sep 1;96(9):E331-E333. doi: 10.1002/ajh.26251. Epub 2021 Jun 2.
2
SARS-CoV-2 vaccination induces breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria on complement inhibitor.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种可在接受补体抑制剂治疗的阵发性夜间血红蛋白尿患者中引发突破性溶血。
Am J Hematol. 2021 Sep 1;96(9):E344-E346. doi: 10.1002/ajh.26262. Epub 2021 Jun 18.
3
Autoantibodies in moderate and critical cases of COVID-19.新冠病毒肺炎中重度和危重症病例中的自身抗体。
Clin Transl Sci. 2021 Sep;14(5):1625-1626. doi: 10.1111/cts.13036. Epub 2021 May 2.
4
Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.COVID-19 患者体内的 SARS-CoV-2 与抗体反应的长期共存。
J Med Virol. 2020 Sep;92(9):1684-1689. doi: 10.1002/jmv.25946. Epub 2020 May 5.
5
Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection.感染后长达10个月的新型冠状病毒2抗体反应动态。
Cell Mol Immunol. 2021 Jul;18(7):1832-1834. doi: 10.1038/s41423-021-00708-6. Epub 2021 Jun 7.
6
Immunology Lessons from the SARS-CoV-2 Pandemic.来自新冠疫情的免疫学经验教训。
Annu Rev Immunol. 2021 Apr 26;39:v-vii. doi: 10.1146/annurev-iy-39-030121-100001. Epub 2021 May 3.
7
Proteomic and phosphoproteomic profiling of COVID-19-associated lung and liver injury: a report based on rhesus macaques.新冠病毒相关肺和肝损伤的蛋白质组学及磷酸化蛋白质组学分析：基于恒河猴的报告
Signal Transduct Target Ther. 2022 Jan 28;7(1):27. doi: 10.1038/s41392-022-00882-7.
8
Immuno-epidemiology and the predictability of viral evolution.免疫流行病学与病毒进化的可预测性
Science. 2022 Jun 10;376(6598):1161-1162. doi: 10.1126/science.abn9410. Epub 2022 Jun 9.
9
Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.新冠肺炎患者疾病过程中恢复期和死亡患者嗜酸性粒细胞计数的变化。
Viruses. 2021 Aug 24;13(9):1675. doi: 10.3390/v13091675.
10
Surveillance and re-positive RNA test in patients recovered from COVID-19.对新冠康复患者的监测及RNA检测复阳情况
J Med Virol. 2021 Mar;93(3):1221-1224. doi: 10.1002/jmv.26568. Epub 2020 Oct 8.

引用本文的文献

1
Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19.不确定潜能的克隆性造血与重症 COVID-19 患者发生血栓栓塞的较高风险相关。
Haematologica. 2025 Sep 1;110(9):2214-2218. doi: 10.3324/haematol.2024.287128. Epub 2025 Mar 20.
2
Clonal hematopoiesis and COVID-19 hospitalization in Danish adults.丹麦成年人中的克隆性造血与新冠病毒疾病住院情况
Hemasphere. 2024 Mar 10;8(3):e58. doi: 10.1002/hem3.58. eCollection 2024 Mar.
3
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients.

本文引用的文献

1
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.阿那白滞素与常规治疗对新冠肺炎合并轻至中度肺炎成人住院患者的疗效（CORIMUNO-ANA-1）：一项随机对照试验
Lancet Respir Med. 2021 Mar;9(3):295-304. doi: 10.1016/S2213-2600(20)30556-7. Epub 2021 Jan 22.
2
Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.单核细胞和巨噬细胞：严重急性呼吸综合征冠状病毒 2 的作用靶点：2019 冠状病毒病免疫麻痹的线索。
J Infect Dis. 2021 Aug 2;224(3):395-406. doi: 10.1093/infdis/jiab044.
3
高通量分析克隆性造血揭示了重症 COVID-19 患者潜在驱动突变的克隆复杂性增加。
PLoS One. 2024 Jan 10;19(1):e0282546. doi: 10.1371/journal.pone.0282546. eCollection 2024.
4
Clonal haematopoiesis - a novel entity that modifies pathological processes in elderly.克隆性造血——一种改变老年人病理过程的新实体。
Cell Death Discov. 2023 Sep 19;9(1):345. doi: 10.1038/s41420-023-01590-z.
5
Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques.恒河猴中克隆性造血对 COVID-19 严重程度和病理生理学影响的研究。
Front Vet Sci. 2023 Jul 6;10:1182197. doi: 10.3389/fvets.2023.1182197. eCollection 2023.
6
Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19.住院 COVID-19 患者中克隆性造血不定潜能的患病率增加。
Front Immunol. 2022 Oct 14;13:968778. doi: 10.3389/fimmu.2022.968778. eCollection 2022.
7
Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease.血液学和心血管疾病中不确定潜能克隆性造血的临床意义
Diagnostics (Basel). 2022 Jul 2;12(7):1613. doi: 10.3390/diagnostics12071613.
8
Clonal hematopoiesis is not significantly associated with COVID-19 disease severity.克隆性造血与新冠病毒疾病严重程度无显著关联。
Blood. 2022 Oct 6;140(14):1650-1655. doi: 10.1182/blood.2022015721.
9
Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study.不确定潜能的克隆性造血与糖尿病肾病：一项巢式病例对照研究。
Kidney Int Rep. 2022 Feb 3;7(4):876-888. doi: 10.1016/j.ekir.2022.01.1064. eCollection 2022 Apr.
Efficacy of canakinumab in mild or severe COVID-19 pneumonia.
卡那奴单抗治疗轻症或重症 COVID-19 肺炎的疗效。
Immun Inflamm Dis. 2021 Jun;9(2):399-405. doi: 10.1002/iid3.400. Epub 2021 Jan 19.
4
An immune-based biomarker signature is associated with mortality in COVID-19 patients.基于免疫的生物标志物特征与 COVID-19 患者的死亡率相关。
JCI Insight. 2021 Jan 11;6(1):144455. doi: 10.1172/jci.insight.144455.
5
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.重症新型冠状病毒肺炎患者的临床生物学特征与克隆性造血
Cancers (Basel). 2020 Jul 21;12(7):1992. doi: 10.3390/cancers12071992.
6
COVID-19 in persons with haematological cancers.COVID-19 与血液系统恶性肿瘤。
Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24.
7
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.COVID-19 患者严重呼吸衰竭的复杂免疫失调。
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.
8
and dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.并主导克隆性造血，表现出良性表型和不同的遗传倾向。
Blood. 2017 Aug 10;130(6):753-762. doi: 10.1182/blood-2017-04-777029. Epub 2017 Jun 27.
9
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.与TET2缺陷相关的克隆性造血加速小鼠动脉粥样硬化发展。
Science. 2017 Feb 24;355(6327):842-847. doi: 10.1126/science.aag1381. Epub 2017 Jan 19.
10
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.从血液DNA序列推断克隆性造血与血癌风险。
N Engl J Med. 2014 Dec 25;371(26):2477-87. doi: 10.1056/NEJMoa1409405. Epub 2014 Nov 26.